Motesanib diphosphate
Motesanib (AMG-706), is an orally bioavailable multiple-receptor tyrosine kinase inhibitor with potential antineoplastic activity. Motesanib selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
NB500-329MFV500 0.1 mL
Mouse Monoclonal CD45RA Antibody (MEM-56) [mFluor Violet 500 SE]
Sign In for Pricing
View Details DCCR002-1.5 1.5 g
Dyed COOH Modified PS Microspheres, 0.50µm, DC03*, Crimson Red
Sign In for Pricing
View Details 